Welcome to our dedicated page for Aleafia Health news (Ticker: ALEAF), a resource for investors and traders seeking the latest updates and insights on Aleafia Health stock.
Aleafia Health Inc. (TSX: AH, OTCQB: ALEAF) is a vertically integrated Canadian cannabis leader with medical clinics, cultivation facilities, and international distribution. This news hub provides investors with essential updates on financial performance, product developments, and strategic initiatives shaping this innovative health and wellness company.
Access timely reports on earnings results, regulatory milestones, and operational updates from Canada's first licensed outdoor cannabis cultivator. Track coverage of Aleafia's medical cannabis education programs, international market expansion, and premium product portfolio including oils, edibles, and therapeutic formats.
Key updates include corporate restructuring developments, cultivation facility operations, and distribution partnerships. Stay informed about Aleafia's progress in creditor protection proceedings and strategic focus on maintaining product quality during financial reorganization.
Bookmark this page for verified updates on Aleafia Health's financial restructuring, adult-use brand performance, and medical cannabis innovations. Monitor official communications regarding asset sales and ongoing commitments to stakeholders.
Aleafia Health Inc. reported its Q3 FY2023 financial results, achieving its second consecutive quarter of positive Adjusted EBITDA at $0.4 million, reflecting a 4% margin. The company saw a 39% growth in adult-use revenue compared to the prior quarter, with a 5% increase year-over-year. Medical net revenue rose by 40%, highlighted by a record $1.1 million in November 2022. Significant cost reductions totaling $21 million over 15 months helped achieve gross profit before fair value adjustments of 37%. Additionally, Aleafia expanded its market reach by entering Manitoba and secured contracts with European partners estimating $1 million and $4.6 million in sales.
Aleafia Health Inc. (OTCQB: ALEAF) will release its fiscal Q3 2023 results on February 13, 2023, before market open. The report covers the period ending December 31, 2022. Following the announcement, a conference call will be held at 8:30 a.m. EST, led by CEO Tricia Symmes and CFO Matt Sale. Interested parties can access the live webcast through the provided link. Aleafia Health, a licensed Canadian cannabis company, operates multiple production facilities and offers a range of cannabis products for both adult-use and medical markets.
FAQ
What is the current stock price of Aleafia Health (ALEAF)?
